Methodological quality assessment of clinical practice guidelines for cervical cancer in China from 2014 to 2018_Chinese Journal of Evidence-Based Medicine

Authors：

HU Feifei ¹ , HE Junyong ² ,  HE Lixia ¹ , CAO Yanpei ¹ , LIU Yun ¹

1. Department of gynaecology and obstetrics, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, 518055, P.R.China;
2. Health Management Center of West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding?author：

HE Lixia, Email: hehelixia@163.com

Keywords：

Cervical cancer; Clinical practice guideline; Consensus; Quality assessment; AGREE Ⅱ

DOI：

10.7507/1672-2531.201901032

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To assess the methodological quality of clinical practice guidelines of cervical cancer in China published from 2014 to 2018.Methods CNKI, WanFang Data, CBM, VIP, Medlive.cn, the National Guideline Clearinghouse, PubMed, The Cochrane Library and EMbase were searched for cervical cancer clinical practice guidelines published in China from January 1^st, 2014 to December 31^st, 2018. Four reviewers searched and selected the literature independently according to the inclusion and exclusion criteria and assessed the methodological quality of the included guidelines by using AGREE Ⅱ.Results A total of 9 guidelines were included. The average score for each area was: scope and purpose 75.47%, stakeholders’ involvement 35.09%, the rigor of development 43.70%, clarity of presentation 87.74%, applicability 80.76%, and editorial independence 0%.Conclusions The quality of cervical cancer clinical practice guidelines in China requires further improvement.

Citation： HU Feifei, HE Junyong, HE Lixia, CAO Yanpei, LIU Yun. Methodological quality assessment of clinical practice guidelines for cervical cancer in China from 2014 to 2018. Chinese Journal of Evidence-Based Medicine, 2019, 19(8): 989-993. doi: 10.7507/1672-2531.201901032 Copy

1.	WHO. World Cancer Report 2014. Available at: http://www.iarc.fr/en/publications/books/wcr/wcr-order.php.
2.	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386.
3.	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
4.	Shekelle PG. Clinical practice guidelines: what's next? JAMA, 2018, 320(8): 757-758.
5.	Brouwers M, Kho ME, Browman GP, et al. AGREE Ⅱ: Advancing guideline development, reporting and evaluation in healthcare. J Clin Epidemol, 2010, 63(12): 1308-1311.
6.	Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
7.	IOM. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press, 2011.
8.	中華預防醫學會婦女保健分會更年期保健學組. 更年期婦女保健指南(2015年). 實用婦科內分泌雜志, 2016, 3(2): 21-32.
9.	國家衛生計生委婦幼健康服務司委托中華預防醫學會婦女保健分會. 子宮頸癌綜合防控指南. 北京: 人民衛生出版社, 2017.
10.	中華醫學會放射學分會宮頸癌專家組. 宮頸癌磁共振檢查及診斷規范專家共識. 腫瘤影像學, 2017, 26(4): 250-254.
11.	福建省海峽兩岸精準醫學協會HPV感染疾病專業委員會. HPV感染疾病相關問題專家共識(2017). 醫學研究生學報, 2017, 30(12): 1238-1241.
12.	中國優生科學協會陰道鏡和宮頸病理學分會(CSCCP)專家委員會. 中國子宮頸癌篩查及異常管理相關問題專家共識(一). 中國婦產科臨床雜志, 2017, 18(2): 190-192.
13.	中國優生科學協會陰道鏡和宮頸病理學分會(CSCCP)專家委員會. 中國子宮頸癌篩查及異常管理相關問題專家共識(二). 中國婦產科臨床雜志, 2017, 18(3): 286-288.
14.	中國醫師協會檢驗醫師分會婦科腫瘤檢驗醫學專家委員會. 婦科腫瘤標志物應用專家共識. 山東大學學報(醫學版), 2018, 56(10): 1-8.
15.	魏麗惠, 趙昀, 謝幸, 等. 妊娠合并子宮頸癌管理的專家共識. 中國婦產科臨床雜志, 2018, 19(2): 190-192.
16.	中國抗癌協會婦科腫瘤專業委員會. 宮頸癌診斷與治療指南(第四版). 中國實用婦科與產科雜志, 2018, 34(6): 613-622.
17.	Zeng ZY, Yang HT, Li ZB, et a1. Prevalence and genotype distribution of hpv infection in China: analysis of 51, 345 HPV genotyping results from China's largest CAP certified laboratory. J Cancer, 2016, 7(9): 1037-1043.
18.	徐信, 陳邦, 左瑞東, 等. 中國胃癌臨床實踐指南的質量評價. 中國循證醫學雜志, 2018, 18(8): 865-870.
19.	李琴, 劉非, 魏永剛, 等. 2016-2017年中國肝癌臨床實踐指南的質量評價. 中國循證醫學雜志, 2018, 18(10): 1109-1113.
20.	蔣朱明, 詹思延, 賈小魏, 等. 制訂/修訂《臨床診療指南》的基本方法及程序. 中華醫學雜志, 2016, 96(4): 250-253.
21.	林夏, 楊克虎, 陳耀龍, 等. 中國臨床實踐指南的現狀與思考. 中國循證醫學雜志, 2017, 17(5): 497-500.
22.	世界衛生組織. 世界衛生組織指南制訂手冊. 楊克虎, 譯. 蘭州: 蘭州大學出版社, 2013.
23.	陳耀龍, 楊克虎, 田金徽, 等. 循證實踐指南的制訂: 國際經驗與中國實踐. 蘭州大學學報(醫學版), 2016, 42(1): 29-35.
24.	韋當, 王聰堯, 肖曉娟, 等. 指南研究與評價(AGREE Ⅱ)工具實例解讀. 中國循證兒科雜志, 2013, 8(4): 316-319.
25.	陳耀龍, 胡嘉元, 李承羽, 等. 中國臨床實踐指南的發展與變革. 中國循證醫學雜志, 2018, 18(8): 787-792.

1. WHO. World Cancer Report 2014. Available at: http://www.iarc.fr/en/publications/books/wcr/wcr-order.php.
2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386.
3. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
4. Shekelle PG. Clinical practice guidelines: what's next? JAMA, 2018, 320(8): 757-758.
5. Brouwers M, Kho ME, Browman GP, et al. AGREE Ⅱ: Advancing guideline development, reporting and evaluation in healthcare. J Clin Epidemol, 2010, 63(12): 1308-1311.
6. Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
7. IOM. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press, 2011.
8. 中華預防醫學會婦女保健分會更年期保健學組. 更年期婦女保健指南(2015年). 實用婦科內分泌雜志, 2016, 3(2): 21-32.
9. 國家衛生計生委婦幼健康服務司委托中華預防醫學會婦女保健分會. 子宮頸癌綜合防控指南. 北京: 人民衛生出版社, 2017.
10. 中華醫學會放射學分會宮頸癌專家組. 宮頸癌磁共振檢查及診斷規范專家共識. 腫瘤影像學, 2017, 26(4): 250-254.
11. 福建省海峽兩岸精準醫學協會HPV感染疾病專業委員會. HPV感染疾病相關問題專家共識(2017). 醫學研究生學報, 2017, 30(12): 1238-1241.
12. 中國優生科學協會陰道鏡和宮頸病理學分會(CSCCP)專家委員會. 中國子宮頸癌篩查及異常管理相關問題專家共識(一). 中國婦產科臨床雜志, 2017, 18(2): 190-192.
13. 中國優生科學協會陰道鏡和宮頸病理學分會(CSCCP)專家委員會. 中國子宮頸癌篩查及異常管理相關問題專家共識(二). 中國婦產科臨床雜志, 2017, 18(3): 286-288.
14. 中國醫師協會檢驗醫師分會婦科腫瘤檢驗醫學專家委員會. 婦科腫瘤標志物應用專家共識. 山東大學學報(醫學版), 2018, 56(10): 1-8.
15. 魏麗惠, 趙昀, 謝幸, 等. 妊娠合并子宮頸癌管理的專家共識. 中國婦產科臨床雜志, 2018, 19(2): 190-192.
16. 中國抗癌協會婦科腫瘤專業委員會. 宮頸癌診斷與治療指南(第四版). 中國實用婦科與產科雜志, 2018, 34(6): 613-622.
17. Zeng ZY, Yang HT, Li ZB, et a1. Prevalence and genotype distribution of hpv infection in China: analysis of 51, 345 HPV genotyping results from China's largest CAP certified laboratory. J Cancer, 2016, 7(9): 1037-1043.
18. 徐信, 陳邦, 左瑞東, 等. 中國胃癌臨床實踐指南的質量評價. 中國循證醫學雜志, 2018, 18(8): 865-870.
19. 李琴, 劉非, 魏永剛, 等. 2016-2017年中國肝癌臨床實踐指南的質量評價. 中國循證醫學雜志, 2018, 18(10): 1109-1113.
20. 蔣朱明, 詹思延, 賈小魏, 等. 制訂/修訂《臨床診療指南》的基本方法及程序. 中華醫學雜志, 2016, 96(4): 250-253.
21. 林夏, 楊克虎, 陳耀龍, 等. 中國臨床實踐指南的現狀與思考. 中國循證醫學雜志, 2017, 17(5): 497-500.
22. 世界衛生組織. 世界衛生組織指南制訂手冊. 楊克虎, 譯. 蘭州: 蘭州大學出版社, 2013.
23. 陳耀龍, 楊克虎, 田金徽, 等. 循證實踐指南的制訂: 國際經驗與中國實踐. 蘭州大學學報(醫學版), 2016, 42(1): 29-35.
24. 韋當, 王聰堯, 肖曉娟, 等. 指南研究與評價(AGREE Ⅱ)工具實例解讀. 中國循證兒科雜志, 2013, 8(4): 316-319.
25. 陳耀龍, 胡嘉元, 李承羽, 等. 中國臨床實踐指南的發展與變革. 中國循證醫學雜志, 2018, 18(8): 787-792.

Previous Article
Quality assessment of clinical practice guidelines on acupuncture
Next Article
Real-world evidence in earthquake emergency medical rescue

Chinese Journal of Evidence-Based Medicine

Methodological quality assessment of clinical practice guidelines for cervical cancer in China from 2014 to 2018

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content